GlassScriptPhysician profile
Timothy J Bray
NPI 1639150568
$11,239.48
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $258 · 2021: $362 · 2022: $157 · 2023: $354 · 2024: $19.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $10,079.84 | 2019-2020 | |
| Stryker Corporation | $406.08 | 2021-2023 | T2 Alpha |
| Smith+Nephew, INC. | $231.76 | 2020-2023 | Evos, Trigen Meta-Nail, Evos Mini |
| Pacira Therapeutics, INC. | $138.11 | 2019 | |
| Acumed LLC | $125.00 | 2021 | |
| Conformis, INC. | $77.38 | 2021 | |
| Kerecis Limited | $47.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $24.24 | 2022 | |
| Next Science LLC | $23.73 | 2023 | Blastx, Surgx, Xperience |
| Si-Bone, INC. | $21.64 | 2023 | |
| Sanara Medtech INC. | $19.41 | 2024 | Celleraterx |
| Davol INC. | $17.95 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $15.08 | 2022 | |
| Baudax Bio INC. | $11.70 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$137,750.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.